analyzed 52 patients with ALK-positive advanced NSCLC at the Cancer Hospital of Chinese Academy of Medical Sciences, and the incidence of pleural metastasis was 36.5% (27). This evidence concerns the gene ALK and non-small cell lung carcinoma.